Trial
NCT00020670
Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
National Cancer Institute (NCI)
Condition
Leukemia
Intervention
CD 40
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-06-20